Evaluation of antineuronal antibodies and 8-OHdG in mothers of children with autism spectrum disorder: a case-control study

References

• Ali NH, Khalaf SK, Al-Asadi JN, Abed AH. 2016. Maternal antineuronal antibodies and risk of childhood autism spectrum disorders: a case-control study. J Chin Med Assoc. 79(12):661–664.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders [DSM-5®]. Arlington (VA): American Psychiatric Publishing.
   Google Scholar
• Arin DM, Bauman ML, Kemper TL. 1991. The distribution of Purkinje cell loss in the cerebellum in autism. Neurology. 41(l):307–308.
   Google Scholar
• Bacon C, Endris V, Rappold G. 2009. Dynamic expression of the Slit-Robo GTPase activating protein genes during development of the murine nervous system. J Comp Neurol. 513(2):224–236.
   PubMed Web of Science ®Google Scholar
• Bayram AK, Kardas F, Demirci EO, Gokahmetoglu S, Ozmen S, Canpolat M, Oztop DB, Kumandas S, Gumus H, Per H. 2016. Lack of serum antineuronal antibodies in children with autism. Bratisl Lek Listy. 117(2):77–79.
   PubMed Web of Science ®Google Scholar
• Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, Nagaraja HN, Cooley WC, Gaelic SE, Bauman ML, et al. 2005. Timing of prenatal stressors and autism. J Autism Dev Disord. 35(4):471–478.
   PubMed Web of Science ®Google Scholar
• Bourgeron T. 2015. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 16(9):551–563.
   PubMed Web of Science ®Google Scholar
• Braunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen RL, Ashwood P, Hertz-Picciotto I, Pessah IN, Van de Water J. 2013. Autism specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry. 3(7):e277–e278.
   PubMedGoogle Scholar
• Bronson SL, Bale TL. 2016. The placenta as a mediator of stress effects on neurodevelopmental reprogramming. Neuropsychopharmacology. 41(1):207–218.
   PubMed Web of Science ®Google Scholar
• Cabanlit M, Wills S, Goines P, Ashwood P, Water JVD. 2007. Brain‐specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci. 1107(1):92–103.
   PubMedGoogle Scholar
• Carlson BR, Lloyd KE, Kruszewski A, Kim I-H, Rodriguiz RM, Heindel C, Faytell M, Dudek SM, Wetsel WC, Soderling SH, et al. 2011. WRP/srGAP3 facilitates the initiation of spine development by an inverse F-BAR domain, and its loss impairs longterm memory. J Neurosci. 31(7):2447–2460.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Chauhan V, Brown WT, Cohen I. 2004. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci. 75(21):2539–2549.
   PubMed Web of Science ®Google Scholar
• Courchesne E, Saitoh O, Yeung-Courchesne R, Press GA, Lincoln AJ, Haas RH, Schreibman L. 1994. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups by MR imaging. AJR. 162(1):123–130.
   PubMed Web of Science ®Google Scholar
• Croen LA, Braunschweig D, Haapanen L, Yoshida CK, Fireman B, Grether JK, Kharrazi M, Hansen RL, Ashwood P, Van de Water J. 2008. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry. 64(7):583–588.
   PubMed Web of Science ®Google Scholar
• Dasdemir S, Guven M, Pekkoc KC, Ulucan H, Dogangun B, Kirtas E, Kadak MT, Kucur M, Seven M. 2016. DNA repair gene XPD Asp312Asn and XRCC4 G-1394T polymorphisms and the risk of autism spectrum disorder. Cell Mol Biol (Noisy-le-Grand). 62(3):46–50.
   PubMed Web of Science ®Google Scholar
• DeBassio WA, Kemper TL, Knoefel JE. 1985. Coffin-Siris syndrome: neuropathological findings. Arch Neurol. 42(4):350–353.
   PubMedGoogle Scholar
• Endris V, Wogatzky B, Leimer U, Bartsch D, Zatyka M, Latif F, Maher ER, Tariverdian G, Kirsch S, Karch D, et al. 2002. The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation. Proc Natl Acad Sci U S A. 99(18):11754–11759.
   PubMed Web of Science ®Google Scholar
• Fox E, Amaral D, Van de Water J. 2012. Maternal and fetal antibrain antibodies in development and disease. Dev Neurobiol. 72(10):1327–1334.
   PubMed Web of Science ®Google Scholar
• Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, Bonassi S. 2012. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med. 52(10):2128–2141.
   PubMed Web of Science ®Google Scholar
• Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG. 2015. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. PLoS One. 10(4):e0123446–46.
   PubMed Web of Science ®Google Scholar
• Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Jaskowski TD, Carlson NG. 2014. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures. J Neuroinflammation. 11:160–161.
   PubMed Web of Science ®Google Scholar
• Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. 2010. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol. 69(10):997–1007.
   PubMed Web of Science ®Google Scholar
• Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH. 2002. Autoantibodies in neuropsychiatric lupus. Autoimmunity. 35(2):79–86.
   PubMed Web of Science ®Google Scholar
• Honnorat J, Antoine JC. 2007. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2:22–23.
   PubMed Web of Science ®Google Scholar
• Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, et al. 2014. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 515(7526):216–221.
   PubMed Web of Science ®Google Scholar
• Karim AR, Hughes RG, El-Lahawi M, Bradwell AR. 2007. Paraneoplastic neurological antibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL, editors. Autoantibodies. Los Angels (CA): Elsevier; p. 627–652.
   Google Scholar
• Kilicaslan F, Ayaydin H, Celik H, Kutuk MO, Kandemir H, Koyuncu I, Kirmit A. 2019. Antineuronal antibodies and 8-OHdG an indicator of cerebellar dysfunction in autism spectrum disorder: a case–control study. Psychiatr Clin Psychopharmacol. 29:840–846.
   Web of Science ®Google Scholar
• Lancaster E, Dalmau J. 2012. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 8(7):380–390.
   PubMed Web of Science ®Google Scholar
• Mazón-Cabrera R, Vandormael P, Somers V. 2019. Antigenic targets of patient and maternal autoantibodies in autism spectrum disorder. Front Immunol. 10:1474.
   PubMed Web of Science ®Google Scholar
• Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, Bellando J, Pavliv O, Rose S, Seidel L, et al. 2012. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord. 42(3):367–377.
   PubMed Web of Science ®Google Scholar
• Meltzer A, Van de Water J. 2017. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology. 42(1):284–298.
   PubMed Web of Science ®Google Scholar
• Morer A, Lazaro L, Sabater L, Massana J, Castro J, Graus F. 2008. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. J Psychiatr Res. 42(1):64–68.
   PubMed Web of Science ®Google Scholar
• Mukaddes NM. 2013. Autism spectrum disorders. İstanbul; Nobel Publishing; p. 11. [Turkish]
   Google Scholar
• Porokhovnik LN, Kostyuk SV, Ershova ES, Stukalov SM, Veiko NN, Korovina NY, Gorbachevskaya NL, Sorokin AB, Lyapunova NA. 2016. The maternal effect in infantile autism: Elevated DNA damage degree in patients and their mothers. Biochem Moscow Suppl Ser B. 10(4):322–326.
   Google Scholar
• Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Pavliv O, Melnyk S, James SJ. 2014. Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a wellmatched case control cohort. PLoS One. 9(1):e85436–10.
   PubMed Web of Science ®Google Scholar
• Sajdel-Sulkowska EM, Xu M, Koibuchi N. 2009. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum. 8(3):366–372.
   PubMed Web of Science ®Google Scholar
• Schopler E, Reichler RJ, DeVellis RF, Daly K. 1980. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 10(1):91–103.
   PubMed Web of Science ®Google Scholar
• Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA. 2014. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathol. 128(6):835–852.
   PubMed Web of Science ®Google Scholar
• Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, Vecht C, Sillevis Smitt P. 2003. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 126(Pt 6):1409–1418.
   PubMed Web of Science ®Google Scholar
• Silva SC, Correia C, Fesel C, Barreto M, Coutinho AM, Marques C, Miguel TS, Ataide A, Bento C, Borges L, et al. 2004. Autoantibody repertoires to brain tissue in autism nuclear families. J Neuroimmunol. 152(1–2):176–182.
   PubMed Web of Science ®Google Scholar
• Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. 2006. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol. 178(1–2):149–155.
   PubMed Web of Science ®Google Scholar
• Singer HS, Morris MC, Gause CD, Gillin PK, Crawford S, Zimmerman AW. 2008. Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol. 194(1–2):165–172.
   PubMed Web of Science ®Google Scholar
• Singh VK, Warren R, Averett R, Ghaziuddin M. 1997. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol. 17(1):88–90.
   PubMed Web of Science ®Google Scholar
• Singh VK, Warren RP, Odell JD, Warren WL, Cole P. 1993. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 7(1):97–103.
   PubMed Web of Science ®Google Scholar
• Soderling SH, Binns KL, Wayman GA, Davee SM, Ong SH, Pawson T, Scott JD. 2002. The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling. Nat Cell Biol. 4(12):970–975.
   PubMed Web of Science ®Google Scholar
• Stich O, Rauer S. 2014. [Paraneoplastic neurological syndromes and autoimmune encephalitis]. Nervenarzt. 85(4):485–498.
   PubMed Web of Science ®Google Scholar
• Sucuog˘Lu B, Oktem F, Akkook F, Gokler B. 1996. A study of the scales for the assessment of the children with autism. 3P Derg. 4(2):116–121. [Turkish]
   Google Scholar
• Talge NM, Neal C, Glover V; Early Stress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health. 2007. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry. 48(3–4):245–261.
   PubMed Web of Science ®Google Scholar
• Trottier G, Srivastava L, Walker CD. 1999. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci. 24(2):103–115.
   PubMed Web of Science ®Google Scholar
• Voltz R, Dalmau J, Posner JB, Rosenfeld MR. 1998. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology. 51(4):1146–50.
   PubMed Web of Science ®Google Scholar
• Ward AJ. 1990. A comparison and analysis of the presence of family problems during pregnancy of mothers of “autistic” children and mothers of normal children. Child Psychiatry Hum Dev. 20(4):279–288.
   PubMed Web of Science ®Google Scholar
• Whitney ER, Kemper TL, Bauman ML, Rosene DL, Blatt GJ. 2008. Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum. 7(3):406–416.
   PubMed Web of Science ®Google Scholar
• Whitney ER, Kemper TL, Rosene DL, Bauman ML, Blatt GJ. 2009. Density of cerebellar basket and stellate cells in autism: evidence for a late developmental loss of Purkinje cells. J Neurosci Res. 87(10):2245–2254.
   PubMed Web of Science ®Google Scholar
• Zimmerman AW, Connors SL, Matteson KJ, Lee L-C, Singer HS, Castaneda JA, Pearce DA. 2007. Maternal antibrain antibodies in autism. Brain Behav Immun. 21(3):351–357.
   PubMed Web of Science ®Google Scholar